Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide pMDI versus placebo in children with asthma
2010-018315-15Phase 2Terminated
- Sponsor
- AstraZeneca
- Start
- Apr 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Budesonide pMDI with Placebo (2 arms). Primary endpoint: Morning peak expiratory flow. Started Apr 2010; status: terminated.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2010-018315-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018315-15.